| GBM | glioblastoma multiforme |
| WHO | World Health Organization |
| CNS | central nervous system |
| IDH | isocitrate dehydrogenase |
| RTK | receptor protein with a tyrosine kinase function |
| RAS | rat sarcoma |
| RAF | rapidly accelerated fibrosarcoma |
| MEK | mitogen-activated kinase |
| ERK | extracellular signal-regulated kinase |
| EGFR | epidermal growth factor receptor |
| EGF | epidermal growth factor |
| TGF-α | transforming growth factor α |
| HIF1 | hypoxia-inducible factor 1 |
| GDP | guanosine diphosphate |
| GTP | guanosine triphosphate |
| PIP3 | phosphatidylinositol (3,4,5)-trisphosphate |
| PIP2 | phosphatidylinositol (4,5)-bisphosphate |
| PKB | protein kinase B |
| BAD | Bcl-2-associated death promoter |
| mTOR | serine/threonine kinase mammalian target of rapamycin |
| mTORC | mTOR complex |
| ATG | autophagy-related genes |
| PI3KC3 | the third class PI3K complex |
| PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit α |
| PIK3R1 | phosphatidylinositol-4,5-bisphosphate 3-kinase regulatory subunit 1 |
| HK2 | hexokinase 2 |
| IL-6 | interleukin 6 |
| JAK/STAT3 | Janus kinase/signal transducer activator of transcription protein |
| PTCH | patched |
| SMO | smoothened |
| NADPH | nicotinamide adenine dinucleotide phosphate |
| NADH | reduced form of nicotinamide adenine dinucleotide |
| D-2HG | D-2-hydroxyglutarate |
| TET | ten–eleven translocation |
| GLUT1 | glucose transporter 1 |
| PDK1 | pyruvate dehydrogenase kinase 1 |
| NMDA | N-methyl-D-aspartate |
| OS | overall survival |
| PFS | progression-free survival |
| O6-BG | O6-benzylguanine |
| miR-198 | microRNA 198 |
| PARP | poly-ADP-ribose polymerases |
| SL | synthetic lethality |
| ATP | adenosine triphosphate |
| IGF | insulin-like growth factor-1 |